CORC

在结果中检索

CORC

浏览/检索结果: 共127条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
人工湿地基质中水质取样和溶解氧测量仪器及取样测量方法 专利
申请日期: 2020-09-18, 公开日期: 2020-09-18
作者:  王少峰;  刘彦汐;  张惠宁;  张玉蓉;  王惠敏
收藏  |  浏览/下载：9/0  |  提交时间：2020/11/11
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：61/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
An Equation Based on Fuzzy Mathematics to Assess the Timing of Haemodialysis Initiation 期刊论文
SCIENTIFIC REPORTS, 2019, 卷号: 9
作者:  Liu, Ying;  Wang, Degang;  Chen, Xiangmei;  Sun, Xuefeng;  Song, Wenyan
收藏  |  浏览/下载：50/0  |  提交时间：2019/12/05
An Equation Based on Fuzzy Mathematics to Assess the Timing of Haemodialysis Initiation 期刊论文
SCIENTIFIC REPORTS, 2019, 卷号: 9, 页码: 5871
作者:  Liu, Ying;  Wang, Degang;  Chen, Xiangmei;  Sun, Xuefeng;  Song, Wenyan
收藏  |  浏览/下载：44/0  |  提交时间：2019/12/02
Are Bus Company Regulations Associated with Crash Risk? Findings from a Retrospective Survey in Four Chinese Cities. 期刊论文
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 卷号: 16, 期号: 8
作者:  Wu, Xiaolin;  Zhang, Huimin;  Xiao, Wangxin;  Ning, Peishan;  Schwebel, David C.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/03
Assessment of dialysis initiation by a fuzzy mathematics equation (ADIFE): a study protocol for a randomised controlled trial 期刊论文
BMJ open, 2019, 卷号: 9, 页码: e023162
作者:  Chen Jilin;  Liu Ying;  Chen Xiangmei;  Sun Xuefeng;  Li Wei
收藏  |  浏览/下载：42/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace